Trial · NCT02860676
Results by group45
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 45
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 1 Adverse Events | Eye disorders | 1 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 2 Adverse Events | Eye disorders | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 3 Adverse Events | Eye disorders | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 4 Adverse Events | Eye disorders | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 1 Adverse Events | Abdominal pain | 1 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 2 Adverse Events | Abdominal pain | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 3 Adverse Events | Abdominal pain | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 4 Adverse Events | Abdominal pain | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 1 Adverse Events | Constipation | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 2 Adverse Events | Constipation | 1 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 3 Adverse Events | Constipation | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 4 Adverse Events | Constipation | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 1 Adverse Events | Gastrointestinal disorders, other | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 2 Adverse Events | Gastrointestinal disorders, other | 1 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 3 Adverse Events | Gastrointestinal disorders, other | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 4 Adverse Events | Gastrointestinal disorders, other | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 1 Adverse Events | Dizziness | 2 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 2 Adverse Events | Dizziness | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 3 Adverse Events | Dizziness | 0 | Adverse Events | |
| Number of Treatment-emergent Adverse Events as Assessed by CTCAE v4.0 | Grade 4 Adverse Events | Dizziness | 0 | Adverse Events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02860676/results